New application for roasted grain seed
Roasted grain seed extracts, particularly from barley, provide effective inhibitors of molybdenum-iron/sulfur-flavin hydroxylase enzymes, addressing the need for accessible products to reduce uric acid levels and prevent associated diseases by inhibiting enzyme activity and oxidative stress.
Patent Information
- Application Number
- JP2023074866
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-28
- Publication Date
- 2024-11-08
AI Technical Summary
There is a growing need for food and drink products that can effectively inhibit molybdenum-iron/sulfur-flavin hydroxylase enzymes to reduce uric acid levels and prevent associated diseases such as hyperuricemia, gout, and other health issues, as current solutions like xanthine oxidase inhibitors from banaba tea may not be widely accessible.
Development of inhibitors derived from roasted grain seeds, particularly barley, which contain components that inhibit molybdenum-iron/sulfur-flavin hydroxylase enzymes, including xanthine oxidoreductase, using extraction methods with water or hydrophilic solvents to obtain active ingredients with specific molecular weights.
The roasted grain seed-derived inhibitors effectively suppress uric acid production and reactive oxygen species generation, providing a natural and accessible solution for preventing and treating diseases associated with elevated uric acid levels and oxidative stress.
Smart Images

Figure 2024159100000007 
Figure 2024159100000001 
Figure 2024159100000002
Abstract
Description
[Technical field]
[0001] The present invention broadly relates to novel uses of roasted grain seeds, such as inhibitors of molybdenum-iron / sulfur-flavin hydroxylase, inhibitors of uric acid production, inhibitors of reactive oxygen species production, and pharmaceutical compositions for the treatment or prevention of diseases requiring inhibition of molybdenum-iron / sulfur-flavin hydroxylase. [Background technology]
[0002] Xanthine oxidoreductase, a member of the molybdenum-iron / sulfur-flavin hydroxylase family of enzymes that contain redox centers for molybdenum, flavin adenine dinucleotide (FAD), and iron / sulfur (Fe / S), is an enzyme that belongs to the purine catabolic pathway and is involved in various diseases.
[0003] Xanthine oxidase, a member of the xanthine oxidoreductase family, metabolizes purines in the liver to produce uric acid. When uric acid is produced excessively in the body or when its excretion is reduced, the blood uric acid level increases, causing various diseases.
[0004] Hyperuricemia is known as a disease in which xanthine oxidoreductase is involved. Hyperuricemia, characterized by serum uric acid levels exceeding 7.0 mg / dL, is a lifestyle-related disease that can lead to significant decline in quality of life, including gout, urinary stones, and kidney damage, and the number of patients with hyperuricemia in Japan has been rapidly increasing in recent years.
[0005] Japanese Patent Application Laid-Open No. 2000-290188 discloses a xanthine oxidase inhibitor derived from banaba tea, a plant that grows in tropical regions such as the Philippines and Indonesia. However, with the number of hyperuricemia patients and those at risk of developing hyperuricemia increasing, there is a growing need for more accessible foods and beverages that can easily lower uric acid levels. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] JP 2000-290188 A Summary of the Invention [Problem to be solved by the invention]
[0007] An object of the present invention is to provide a novel molybdenum-iron / sulfur-flavin hydroxylase inhibitor derived from a food or drink, and the like. [Means for solving the problem]
[0008] The present inventors have discovered that an extract of seeds obtained by roasting grains such as barley contains a high content of components that inhibit the activity of molybdenum-iron / sulfur-flavin hydroxylase, and have thus completed the present invention.
[0009] That is, the present invention includes the following inventions. [1] An inhibitor of molybdenum-iron / sulfur-flavin hydroxylase, containing as its active ingredient a component derived from roasted grain seeds. [2] The inhibitor according to [1], wherein the molybdenum-iron / sulfur-flavin hydroxylase is a xanthine oxidoreductase (XOR) selected from the group consisting of xanthine oxidase (XOD) and xanthine dehydrogenase (XDH). [3] The inhibitor according to [1] or [2], wherein the active ingredient is extracted with water or a hydrophilic solvent. [4] The inhibitor according to [1] or [2], wherein the molecular weight of the active ingredient is 5,000 or less, 3,000 or less, or 1,000 or less. [5] The inhibitor according to [1] or [2], wherein the molecular weight of the active ingredient is 100 or more. [6] The inhibitor according to [1] or [2], wherein the cereal grain is one or more selected from the group consisting of barley, rye, oats, soybean, pearl barley, corn and rice. [7] The inhibitor according to [1] or [2], wherein the barley is one or more types selected from the group consisting of six-row barley and two-row barley. [8] A uric acid production inhibitor comprising the inhibitor according to [1] or [2] as an active ingredient. [9] An agent for suppressing the production of reactive oxygen species, comprising the inhibitor according to [1] or [2] as an active ingredient.
[10] A food or beverage comprising the inhibitor described in [1] or [2], the uric acid production inhibitor described in [8], or the reactive oxygen species production inhibitor described in [9].
[11] A supplement comprising the inhibitor described in [1] or [2], the uric acid production inhibitor described in [8], or the reactive oxygen species production inhibitor described in [9].
[12] A pharmaceutical composition for the treatment or prevention of a disease in which inhibition of molybdenum-iron / sulfur-flavin hydroxylase is required, comprising as an active ingredient a component derived from roasted cereal seeds.
[13] The pharmaceutical composition according to
[12] , wherein the disease is selected from the group consisting of hyperuricemia, inflammation, autoimmune diseases, pulmonary diseases, cardiovascular diseases, sickle cell disease and cancer.
[14] A method for producing a fraction containing components that inhibit molybdenum-iron / sulfur-flavin hydroxylase, comprising the step of subjecting roasted grain seeds to extraction with one or more solvents selected from the group consisting of water and hydrophilic solvents.
[15] The method according to
[14] , further comprising a step of fractionating the extracted fraction according to molecular weight. Effect of the Invention
[0010] According to the present invention, inhibitors of molybdenum-iron / sulfur-flavin hydroxylase and the like are obtained by using roasted grains and extraction methods commonly used in the production of barley tea. Inhibitory activity may vary depending on the grains used and other factors, but when barley is used as the starting material, fractions with higher inhibitory activity are obtained as the L value decreases. The active ingredient is not specified and is not intended to be limiting, but it is assumed from the results of the examples that it has a molecular weight of 1,000 or less and is soluble in methanol or hot water. [Brief description of the drawings]
[0011] [Figure 1] FIG. 1 illustrates the procedure for fractionating the extract of Example 6. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] Hereinafter, the embodiments or implementations of the present invention will be described in detail, however, the present invention is not limited to these and various modifications are possible without departing from the gist of the present invention.
[0013] (Molybdenum-iron / sulfur-flavin hydroxylase inhibitors) In one embodiment, there is provided an inhibitor of molybdenum-iron / sulfur-flavin hydroxylase, comprising as an active ingredient an ingredient derived from roasted cereal seeds.
[0014] As used herein, "molybdenum-iron / sulfur-flavin hydroxylase" refers to an enzyme that has molybdenum, flavin adenine dinucleotide (FAD), and iron / sulfur (Fe / S) redox centers and is synonymous with molybdenum-containing iron / sulfur flavoprotein, molybdenum-containing hydroxylase, and molybdenum enzyme.
[0015] Enzymes that require molybdenum usually use molybdopterin as a cofactor, so molybdenum-iron / sulfur-flavin hydroxylases can also be described as enzymes that use molybdopterin as a cofactor. Examples of molybdenum-iron / sulfur-flavin hydroxylases include, but are not limited to, xanthine oxidase, xanthine dehydrogenase, dimethyl sulfoxide reductase, sulfite oxidase, nitrate reductase, ethylbenzene hydroxylase, glyceraldehyde-3-phosphate dehydrogenase (ferredoxin), arsenate reductase (glutaredoxin), carbon monoxide dehydrogenase, and aldehyde oxidase.
[0016] The above examples of molybdenum-iron / sulfur-flavin hydroxylases include family members of each enzyme or their homologs. The xanthine oxidase family includes xanthine oxidoreductase (XOR). As used herein, "homolog" refers to a protein and / or gene that shares a common ancestor with the original protein and / or gene and has a similar function and / or sequence. In the present specification, the term "homolog" is broad and includes orthologs and paralogs.
[0017] In one embodiment, the xanthine oxidoreductase (XOR) is selected from the group consisting of xanthine oxidase (XOD) and xanthine dehydrogenase (XDH). As a member of the xanthine oxidase family, xanthine oxidase is preferred.
[0018] As used herein, "inhibition of molybdenum-iron / sulfur-flavin hydroxylase" means that the enzyme activity of molybdenum-iron / sulfur-flavin hydroxylase is reduced or eliminated (inactivated) as compared to a control. The inhibitory activity of molybdenum-iron / sulfur-flavin hydroxylase can be measured using a known method for evaluating xanthine oxidase inhibitory activity. For example, since xanthine oxidase oxidizes hypoxanthine to xanthine and uric acid, the amount of these substrates or products can be used as an indicator to evaluate the xanthine oxidase inhibitory activity.
[0019] As used herein, "cereal" refers to a crop whose seeds are edible and which is used as a raw material for food and beverages by being subjected to extraction with a solvent such as water or an organic solvent. The grain is preferably a crop that is subjected to a roasting process and a subsequent extraction process using water or a hydrophilic solvent, and that produces a fraction containing a component having a molecular weight of 5,000 or less, 4,000 or less, 3,000 or less, 2,000 or less, preferably 3,000 or less, more preferably 1,000 or less, and that has an inhibitory activity against molybdenum-iron / sulfur-flavin hydroxylase. Examples of such grains include plants belonging to the Poaceae, Fabaceae, Polygonaceae, Amaranthaceae, etc. that are used for food, specifically cereals, pulses such as wheat, rice, and beans, and pseudocereals. Examples of wheat include barley, rye, oats, Job's tears, and wheat. Examples of beans include soybeans (black soybeans, etc.), sword beans, etc. Other grains include corn, rice (brown rice, etc.), sorghum, millet, barnyard millet, foxtail millet, buckwheat, amaranth, quinoa, etc.
[0020] Even with the same extraction method, the degree of inhibitory activity of molybdenum-iron / sulfur-flavin hydroxylase in the obtained fraction and extraction efficiency vary depending on the type of grain and the state of the grain at the time of extraction (whether it is crushed or not, etc.). For example, from the viewpoint of obtaining a fraction with a high degree of activity by subjecting roasted grain seeds to a process of extraction with one or more solvents selected from the group consisting of water and hydrophilic solvents, among grains, wheat, such as barley, rye, oats, etc., are preferred as raw materials. In the case of pearl barley, it is preferable to use unthreshed pearl barley. As for soybeans, black soybeans are preferred over germ soybeans.
[0021] The variety of barley is not particularly limited, and examples thereof include two-row barley such as Latrobe, Hindmarsh, Metcalf, Scope, Commander, Hoshun, and Mikamo Golden; four-row barley; six-row barley such as Legacy, Shunrai, Fiber Snow, Kashimamugi, Minorimugi, Masakadomugi, and Suzukaze; and naked barley such as Daishimochi. Among these, barley used as a raw material for barley tea, for example, two-row barley and six-row barley, are preferred.
[0022] In this specification, the term "roasted grain" refers to grain that has been processed by heating and roasting, and preferably has a degree of roasting that is neither too light nor too deep. The roasted grain may be in any state, such as whole (round grain), crushed, or pulverized, but is preferably pulverized when the extraction efficiency is the most important factor. The degree of roasting can be evaluated using the L value in the Hunter Lab color system. In the Hunter Lab color system, the numerical value of the color is indicated by Lab, and the a value and b value represent the hue and saturation. As used herein, the L value is the lightness of the roasted grain measured with a color difference meter when black is L value 0 and white is L value 100.
[0023] The level of roast can also be evaluated using the L value in the L*a*b* (L-star-A-star-B-star) color system, which was standardized by the International Commission on Illumination (CIE) and is also adopted in Japan in JIS (JIS Z 8781-4). However, since there is no conversion formula between this and the Hunter Lab color system, in this specification the level of roast is expressed using values in the Hunter Lab color system.
[0024] The L value is generally measured by the grain L value, which is measured without crushing uncrushed grains, and the crushed L value, which is measured after crushing, but unless otherwise specified, the L value in this specification refers to the crushed L value. The reason for adopting the crushed L value is that the L values of the outer surface and the center of the grain do not necessarily show the same value, so in order to know the degree of change of the entire grain, especially the grain caused by roasting, it is preferable to homogenize all the grains as powder and measure the L value of the surface color. From this perspective, the crushed L value is used as an index to evaluate the degree of roasting. The crushing method will be described later.
[0025] From the viewpoint of obtaining the active ingredient of the inhibitor, the L value is adjusted within the range of 10 to 80. The lower the L value, the higher the inhibitory activity tends to be, and the upper limit is preferably 75, more preferably 70. The preferred L value, particularly the lower limit, varies depending on the type of grain, but in the case of barley, the range of 10 to 50 is preferred. In order to obtain a fraction with a higher inhibition rate, the L value is preferably within the range of 15 to 35, more preferably within the range of 15 to 25, and even more preferably within the range of 15 to 20. From the viewpoint of extraction efficiency, the L value is preferably within the range of 15 to 45, more preferably within the range of 25 to 40, and more preferably within the range of 20 to 35. However, the L value may be changed not only by the inhibition rate but also by other factors, such as the form of the final product. For example, in the case of luxury goods such as beverages, it is necessary to consider the flavor, so the lower limit of the L value is about 20, as described below.
[0026] The L value can be adjusted by changing the heating temperature and heating time. For example, the L value can be decreased by increasing the roasting temperature or extending the roasting time, and vice versa.
[0027] There are no particular limitations on the cultivation method of the grains used as raw materials or the timing of harvesting the seeds. The seeds may be hulled or may have had the husk removed by threshing. Although the components of the seeds differ depending on the part of the seed, whole grains that have not been threshed can be used for the subsequent processing.
[0028] The active ingredient is extracted from the seeds of roasted grains. Examples of roasting processes include medium roasting, hot air roasting, sand roasting, far-infrared roasting, open kettle roasting, and rotary drum roasting. The heating conditions in the roasting process can be appropriately determined by a person skilled in the art according to the desired roasting degree. For example, in the case of medium roasting, the methods shown in Patent 4456178 and JP 2020-068759 can be mentioned. In the case of hot air roasting, for example, when a small batch roaster of about 5 kg is used, the temperature reached at the time of discharge is appropriately adjusted to about 180 to 280 ° C, preferably 190 to 230 ° C, and more preferably 200 to 220 ° C. The heating conditions can be changed depending on the desired effect and the type of grain. For example, when obtaining the desired fraction by hot air roasting in the aforementioned small batch roaster, the temperature is preferably 190 to 220°C for six-row barley and 210 to 215°C for two-row barley, but is not limited to these, and each condition is appropriately adjusted based on the crushing L value of the seeds obtained after heat processing.
[0029] The roasting process may be carried out one or more times under different conditions. After the roasting process, the seeds may be cooled before being subjected to the next process. The cooling method is not limited, and examples thereof include standing to cool, cooling with air, and cooling with water.
[0030] The seeds may be roasted or ground after roasting as necessary. In the grinding process, a person skilled in the art can appropriately select a known grinder such as a mill type grinder, a pin mill grinder, or a powder grinder according to the desired particle size and quality of the particles. When the particle size after grinding is set, the ground grains can be sieved through a sieve of the desired mesh size to remove unground particles. The degree of grinding may be determined comprehensively from the extraction efficiency, flavor, etc.
[0031] In order to objectively confirm the degree of roasting, the roasted seeds are crushed to a uniform state, and the L value of the surface color is measured using a color difference meter. The crushing method is not particularly limited as long as it is a dry type, and may be a mill type crusher, a pin mill crusher, a powder crusher, etc., as long as the roasted seeds are crushed appropriately and uniformly and no uncrushed material remains that can be visually recognized as grains. After confirming that there are no uncrushed material with large particle sizes after crushing, the surface color is measured with a color difference meter and the L value is recorded. The degree of crushing may be confirmed as long as there is no deviation or interference in the measured value when measuring the surface color with a color difference meter, and the confirmation may be visual.
[0032] As a pre-roasting treatment, the grains may be subjected to a swelling treatment in which the grains are brought into a moist state by contacting them with water or steam. By carrying out such swelling treatment, the seeds containing moisture are heated at a high temperature so that they swell and crack, and the extraction efficiency can be further improved.
[0033] As described above, the method of the swelling treatment may include a method of contacting the raw material with water. For example, the method of soaking the seeds in water, directly spraying water on the seeds, or contacting the seeds with water by steam spraying may be exemplified, but the swelling treatment method is not limited to these.
[0034] In order to prevent deterioration of the quality of the seeds, it is preferable to cool the seeds after heating. The cooling method is not particularly limited. For example, cooling by standing, cooling with air, cooling with water, etc. can be exemplified.
[0035] The active ingredient is extracted from the raw material using water or a hydrophilic solvent. Examples of water include pure water, tap water, distilled water, desalted water, alkaline ionized water, lake water, deep sea water, ion-exchanged water, deoxygenated water, natural water, hydrogen water, etc. From the viewpoint of efficiency during extraction and stability of ingredients, water with as few solutes or impurities as possible is preferred, and pure water, distilled water, and desalted water are preferred. Examples of hydrophilic solvents include alcohols such as methanol, ethanol, propanol, and butanol. As a hydrophilic solvent, ethanol is preferred for food applications.
[0036] The extraction time varies depending on factors such as the type of grain and solvent used, the degree of roasting, whether or not crushing is performed, and the amount of the desired active ingredient, but is not particularly limited as long as the temperature is such that the active ingredient can be appropriately dissolved. The water and hydrophilic solvent used for extraction may be heated in advance to improve the extraction efficiency. Other extraction conditions may also be changed as appropriate. For example, the extraction may be performed once or multiple times, and when multiple extractions are performed, the type of solvent may be changed each time. A different type of solvent may be used for each step, but the same type of solvent may also be used. In addition, water whose pH has been adjusted to a range that does not affect the deterioration of the ingredients may be used, taking into account the effect on the extraction efficiency and flavor.
[0037] The extraction temperature varies depending on factors such as the type of grain and solvent used, the degree of roasting, the presence or absence and degree of grinding, and further the amount of the desired active ingredient, but is not particularly limited as long as the temperature is such that the active ingredient can be appropriately dissolved. For example, when the grain is barley or other wheat, and the extraction method is immersion extraction using water, the same conditions as those used in the production method of barley tea can be used. Such conditions include extraction at low or high temperatures for several minutes or more, for example, at 2 to 140°C for 5 minutes or more, but are not limited to such conditions as long as the desired active ingredient is extracted. From the viewpoint of extraction efficiency, it is preferable to extract by heating the solvent to room temperature or higher. Furthermore, the extraction efficiency may be improved by performing the extraction under a pressure higher than atmospheric pressure. When the extraction of active ingredients from barley or other wheat is performed at atmospheric pressure, the heating conditions are preferably 90°C or higher for 10 to 20 minutes or more, and more preferably 95°C or higher for 20 to 30 minutes or more and less than 720 minutes. A stirring process may be performed during extraction to perform the extraction more efficiently. In addition, the extraction efficiency is improved by adding crushed raw materials.
[0038] As an extraction method, in addition to immersion extraction, known methods such as column extraction, batch extraction, drip extraction, and showering extraction can be used.
[0039] The liquid after extraction may be subjected to a filtration process, if necessary, depending on the form of the final product. For example, when purifying or concentrating an active ingredient, column chromatography using resins or membrane filtration is generally used. In this case, solids that interfere with passing the liquid through each process are removed by filtration or the like. In addition, when the final product is a beverage, particularly a bottled beverage, the presence of solids causes problems such as poor appearance, so it is preferable to remove the solids by filtration. The filtration method is not particularly limited, and known means using flannel filter cloth, filter paper, filter plate, filter, column, etc. may be used. Instead of filtration, solids may be separated by centrifugation or the like.
[0040] The above steps may be substituted with steps carried out in the manufacture of beverages using typical roasted barley, such as barley tea beverages. The steps in the manufacturing method of such beverages include, for example, steps of removing foreign matter, adjusting pH, sterilizing, etc., after extracting from roasted seeds with hot water using a large extractor, but there is no particular restriction on the manufacturing method as long as the effective ingredient is ultimately extracted.
[0041] The extract obtained in the above steps is stored under suitable conditions until use in order to keep the eluted components stable. For example, the extract may be filtered through a sieve or flannel to remove unnecessary components and residues, and the filtrate may be frozen, or excess water may be removed by a suitable concentration method, such as vacuum concentration, freeze-drying, spray-drying, etc., before storage. Depending on the application, the extract may be used as is, or immediately after appropriate dilution or concentration.
[0042] As used herein, "molecular weight" refers to the nominal molecular weight cutoff of the ultrafiltration membrane used. For example, when a liquid is passed through a membrane of molecular weight X, "less than X" refers to the filtered component, and "more than X" refers to the remaining component.
[0043] When purifying an active ingredient, the fractionation can be carried out by a known method, for example, liquid-liquid distribution, separation using a carrier such as separation silica gel, resin, gel filtration material, cellulose, diatomaceous earth, minerals, etc., as well as dialysis and ultrafiltration membranes to obtain a fraction containing an active ingredient with a molecular weight within a desired range. Liquid-liquid distribution can be performed using a general separatory funnel or a countercurrent distribution method. As a method using a carrier, in the case of separation silica gel, in addition to silica gel, chemically bonded silica gel, for example, silica gel whose surface is modified with octadecyl groups, octyl groups, amino groups, etc., can be used, and development can be carried out with a normal phase solvent, reverse phase solvent, etc. In addition, the method of using resins includes, for example, developing synthetic adsorbents such as Diaion HP20, HP2MGL, Sepabeads SP70, SP850, SP207 (all manufactured by Mitsubishi Chemical), Amberlite XAD-2, XAD-2000 (all manufactured by Organo), or ion exchange resins such as Diaion SK series, WK series, SA series, WA series (all manufactured by Mitsubishi Chemical) with an appropriate solvent. Examples of gel filtration materials include Sephadex series (manufactured by Cytiva) and Toyopearl HW series (manufactured by Tosoh). Examples of diatomaceous earth include separation diatomaceous earth and Celite, and examples of minerals include white clay (activated / acidic) and alumina. Examples of membranes used in dialysis include the Dialysis Membrane series (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.), and examples of ultrafiltration membranes include the Omega Membrane series (manufactured by Nippon Pall) and Amicon series (manufactured by Sigma-Aldrich). These separation techniques may be used alone or in combination. In the case of using multiple techniques, the combination and order may be appropriately selected as long as the active ingredient is efficiently purified. Furthermore, there are no limitations on the carriers and techniques used, and other than those listed above may also be used.
[0044] (Uric acid production inhibitor) In one embodiment, there is provided an agent for suppressing uric acid production, comprising as an active ingredient an inhibitor of molybdenum-iron / sulfur-flavin hydroxylase derived from roasted grain seeds.
[0045] Molybdenum-iron / sulfur-flavin hydroxylase inhibitors can suppress the metabolism of purines such as xanthine and hypoxanthine into uric acid in the body, thereby inhibiting the production of uric acid, and are therefore intended to have the same function as commercially available uric acid production inhibitors such as allopurinol, etc. In the present specification, the inhibition of uric acid production can be evaluated by a reduction in the concentration of uric acid in a biological sample, for example, in blood or urine.
[0046] When the ingredient derived from roasted grain seeds is used as an active ingredient of a uric acid production inhibitor, it can also be used in combination with other known active ingredients of pharmaceuticals used for the treatment and improvement of hyperuricemia, gout, etc., such as allopurinol, magnesium, citrate, etc.
[0047] (Reactive oxygen species production inhibitor) In one embodiment, there is provided an agent for suppressing reactive oxygen species production, comprising as an active ingredient an inhibitor of molybdenum-iron / sulfur-flavin hydroxylase derived from roasted grain seeds.
[0048] Xanthine oxidase generates reactive oxygen species in the process involved in the metabolism of purines such as xanthine and hypoxanthine into uric acid. Therefore, inhibitors of molybdenum-iron / sulfur-flavin hydroxylase can function as reactive oxygen species generation inhibitors. As used herein, "reactive oxygen species" is a general term for oxygen-derived highly reactive oxygen species, examples of which include superoxide, hydrogen peroxide, and hydroxyl radicals. Inhibition of reactive oxygen species generation in this specification can be evaluated by reducing the concentration of reactive oxygen in a biological sample, for example, in blood or urine.
[0049] When ingredients derived from roasted grain seeds are used as active ingredients for inhibiting the production of reactive oxygen species, they can also be used in combination with other known active ingredients, such as enzymes such as catalase and superoxide dismutase (SOD), and endogenous antioxidants such as ascorbic acid and glutathione.
[0050] (Food and drink composition) In one embodiment, a food or beverage composition comprising a uric acid production inhibitor or an inhibitor of reactive oxygen species production is provided.
[0051] Since the active ingredient for suppressing uric acid production or suppressing reactive oxygen species production is derived from the seeds of grains such as barley, the food and drink composition may be a food and drink made from the seeds of grains such as barley, such as barley tea. The fraction containing the active ingredient can be concentrated and incorporated into products such as supplements that aim to suppress uric acid production or reactive oxygen species production.
[0052] The food and drink composition can be in the form of a solid, semi-solid or liquid. As the food and drink, the form of a beverage such as barley tea is preferred. As long as the beverage contains the ingredient derived from the roasted grain seed, the obtained ingredient may be diluted or concentrated.
[0053] The L value of the roasted grain used is not particularly limited as long as it has the desired effect, but as described above, the L value suitable for use as a beverage in which not only inhibitory activity but also taste is an important factor is 20 or more, and the L value is preferably in the range of 20 to 50. If the L value is less than 20, it will have a burnt smell, and if it exceeds 50, the aroma and flavor of raw barley will remain, and since the roasting is insufficient, the starch quality will not change sufficiently, and for example, when it is made into a bottled beverage, if it is stored for a long period of time, a large amount of sediment will be generated due to starch retrogradation over time, resulting in a poor appearance, which is not preferable.
[0054] The composition may contain other ingredients in addition to the active ingredient of the uric acid production inhibitor or the active oxygen species production inhibitor. Such other ingredients include ingredients other than the active ingredient derived from the seeds of grains such as barley, such as mineral ingredients, vitamins, acidulants, antioxidants, sweeteners, colorants, etc. In the case of a solid form, excipients, disintegrants, lubricants, etc. may be appropriately blended.
[0055] The food and drink composition may be filled in a container. When filling the container with the active ingredient of the uric acid production inhibitor or the reactive oxygen species production inhibitor, additives such as antioxidants such as ascorbic acid and sodium ascorbate, flavorings, pH adjusters such as sodium bicarbonate, emulsifiers, preservatives, sweeteners, colorants, thickening stabilizers, seasonings, and strengthening agents may be added alone or in combination, as necessary.
[0056] Examples of containers for filling the food and drink compositions include glass bottles, molded containers mainly made of polyethylene terephthalate (PET bottles), plastic containers such as multi-layer molded containers, paper containers, and metal containers.
[0057] The food and drink composition may be in the form of a supplement, such as a tablet or capsule. As used herein, the term "supplement" is intended to be used as any health food, such as a nutritional supplement, a dietary supplement, a functional food, a health food, a food for specified health uses, a food with nutritional function, a food for special uses, etc. In the case of a supplement, the inhibitory activity is more important than the flavor of roasting, so the upper limit of the L value may be less than 20.
[0058] The food and drink composition can be used for any application related to the inhibition of molybdenum-iron / sulfur-flavin hydroxylase. For example, the food and drink composition can be used for the prevention or treatment of a disease in which inhibition of molybdenum-iron / sulfur-flavin hydroxylase is required. Such a disease may be any disease caused by increased enzyme activity of molybdenum-iron / sulfur-flavin hydroxylase, or an increase in uric acid concentration or an increase in reactive oxygen species. The disease in which inhibition of molybdenum-iron / sulfur-flavin hydroxylase is required may be either systemic or local.
[0059] In one embodiment, the disease in which inhibition of molybdenum-iron / sulfur-flavin hydroxylase is required is selected from the group consisting of hyperuricemia, inflammation, autoimmune diseases, pulmonary diseases, cardiovascular diseases, cerebrovascular diseases, renal diseases, sickle cell disease and cancer.
[0060] Hyperuricemia refers to a state in which the concentration of uric acid in the blood is high, and for example, when the uric acid in the blood exceeds 7.0 mg / dl, hyperuricemia can be diagnosed. Hyperuricemia can be classified into four types: excessive uric acid production type, decreased uric acid excretion type, mixed type of excessive production and decreased excretion type, and extrarenal decreased excretion type.
[0061] Diseases resulting from hyperuricemia, such as gout, renal dysfunction, uremia, urinary tract stones, arteriosclerosis, myocardial infarction, cerebral infarction, and the like, can also be included in the diseases requiring inhibition of molybdenum-iron / sulfur-flavin hydroxylase.
[0062] Examples of inflammation include, but are not limited to, joint inflammation such as rheumatoid arthritis and osteoarthritis; inflammatory bowel diseases such as ulcerative colitis and Crohn's disease; inflammatory lung diseases such as asthma and chronic obstructive airway disease; inflammatory eye diseases such as corneal dystrophy, trachoma, onchocerciasis, uveitis, sympathetic ophthalmia, and endophthalmitis; inflammatory gum diseases such as periodontitis and gingivitis; inflammatory kidney diseases such as acute uric acid nephropathy, acute renal failure, glomerulonephritis, and nephrosis; inflammatory skin diseases such as acne, sclerosing dermatitis, psoriasis, eczema, photoaging, and wrinkles; inflammatory central nervous system diseases such as encephalomyelitis, viral or autoimmune encephalitis, and inflammatory heart diseases such as cardiomyopathy.
[0063] Examples of autoimmune diseases include, but are not limited to, scleroderma, systemic lupus erythematosus, rheumatoid arthritis, and the like.
[0064] Examples of lung diseases include, in addition to the specific examples of inflammatory lung diseases mentioned above, chronic lung disorders, sleep apnea syndrome (SAS), pulmonary hypertension, and the like.
[0065] Examples of cardiovascular diseases include, but are not limited to, hypertension, heart failure, atrial fibrillation, arteriosclerosis, and the like.
[0066] Examples of cerebrovascular diseases include, but are not limited to, cerebral infarction, cerebrovascular dementia, and the like.
[0067] Examples of kidney diseases include, but are not limited to, kidney damage, kidney stones, and urinary stones, in addition to the specific examples of kidney inflammatory diseases mentioned above.
[0068] Examples of cancer include cancers that occur in association with an increase in uric acid level, such as cancers occurring in the respiratory tract, digestive tract, mammary glands, reproductive organs, and the like.
[0069] The disease requiring inhibition of molybdenum-iron / sulfur-flavin hydroxylase may be a disease caused by expression of reactive oxygen species or a health disorder mediated by an enzyme. Inhibition of molybdenum-iron / sulfur-flavin hydroxylase is expected to reduce oxidative stress, and thus improve vascular endothelial function and suppress the production of reactive oxygen species from cell damage such as ischemic conditions. Examples of diseases requiring improvement of vascular endothelial function include cardiovascular diseases, such as hypertension. Examples of diseases requiring suppression of the production of reactive oxygen species from cell damage such as ischemic conditions include various inflammations. The disease causing expression of reactive oxygen species or the health disorder mediated by an enzyme may be selected from the group consisting of inflammation, autoimmune diseases, lung diseases, cardiovascular diseases, sickle cell disease, and cancer.
[0070] (Manufacturing method) In one embodiment, there is provided a method for producing a fraction containing components that inhibit molybdenum-iron / sulfur-flavin hydroxylase, comprising subjecting roasted grain seeds to extraction with one or more solvents selected from the group consisting of water and hydrophilic solvents.
[0071] As described above, the extraction conditions vary depending on the type of grain and the state of the grain at the time of extraction (whether it is crushed or not, etc.), but a person skilled in the art can determine appropriate conditions depending on the desired level of inhibitory activity.
[0072] The obtained fraction can be further subjected to a fractionation / purification step. The fractionation / purification can be carried out by known methods as described above, for example, liquid-liquid partitioning, separation using a carrier such as separation silica gel or resin, gel filtration material, cellulose, diatomaceous earth, minerals, etc., as well as dialysis or ultrafiltration membrane.
[0073] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. EXAMPLES
[0074] Example 1: Evaluation of xanthine oxidase inhibitory activity A known method (T. Hatano et al., Chem. Pharm. Bull., 38, 1224 (1990) and R. Tanaka et al., Gout and Nucleic Acid Metabolism, 37, 117 (2013)) was modified to evaluate the inhibitory activity against the enzyme by measuring the amount of uric acid produced or the amount of xanthine reduced by reacting xanthine with xanthine oxidase (XOD) in the presence of the test substance. The detailed procedure is as follows.
[0075] (Preparation of working solutions) 7.6 mg of xanthine (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) was dissolved in 500 mL of pH 7.6 phosphate buffer (0.1 M, hereafter referred to as "buffer") to prepare a 0.1 mM xanthine solution (hereafter referred to as "xanthine solution"). As a positive control, 6.8 mg of allopurinol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) was dissolved in 50 mL of buffer to prepare a control stock solution, which was then appropriately diluted and used (hereafter referred to as "positive control solution"). 8 μL of xanthine oxidase (XA4500 derived from buttermilk, manufactured by Sigma-Aldrich Co., Ltd.) was dissolved in buffer and the volume was adjusted to 25 mL to prepare a xanthine oxidase solution (hereafter referred to as "enzyme solution"). The test substance solution (assay solution) was prepared by dissolving in buffer or buffer mixture (buffer:DMSO = 1:1) taking into consideration the final concentration. The xanthine solution and positive control solution were frozen after preparation and thawed for appropriate use during the evaluation test. The enzyme solution and the test substance solution were prepared immediately before the evaluation.
[0076] (reaction) According to Table 1, each solution was added to a 1.5 mL microtube and reacted for 50 minutes at 37°C in a thermostatic water bath using a thermostatic device (AS ONE THEMO MAX TM-1). After the reaction time, 25 μL of 1 M hydrochloric acid was added to each microtube to stop the reaction. [Table 1] (*) If a buffer mixture is used to dissolve the sample,
[0077] (analysis) After the reaction, all the contents of the microtube were filtered through an HPLC filter (Nihon Pall Ekicrodisc 13CR 0.45 μm / φ13 mm) to remove insoluble matter, and then subjected to analysis using HPLC (Waters 2695 Separation Module) and an ultraviolet absorption detector (Waters 2487 Dual Wavelength Absorbance Detector). The analysis conditions were as follows: Column: COSMOSIL 5C18-ARII (φ4.6mm×250mm, Nacalai Tesque) Guard column: COSMOSIL 5C18-ARII (φ4.6mm×10mm, Nacalai Tesque) Mobile phase (A): 30 mM phosphoric acid aqueous solution (B) 60% acetonitrile Gradient program: 0-14 min (A:B = 100:0, same below) -> 15-21 min (20:80) -> 22-30 min (100:0) Flow rate: 1mL / min Column temperature: 30℃ Sample holding temperature: 15℃ Detection: 269nm (xanthine) and 295nm (uric acid)
[0078] (Inhibitory activity evaluation) The inhibitory activity was evaluated based on the inhibition rate calculated by the following formula.
[0079] [Xanthine reduction amount standard Inhibition rate (Inhibition rate XA (The same applies below.) Xanthine retention time: approx. 9.8 min Inhibition rate XA (%) =[1-(area XA Blank -area XA Test ) / area XA Blank] x 100 Here, the area XA " indicates the peak area of xanthine in the chromatogram.
[0080] [Uric acid production standard inhibition rate (inhibition rate UA (The same applies below.) Uric acid retention time: approx. 7.6 minutes Inhibition rate UA (%) =[1-(area UA Specimen Test -area UA Specimen Blank ) / (area UA Control Test -area UA Control Blank )] x 100 Here, the area UA " indicates the peak area of uric acid in the chromatogram.
[0081] In selecting the evaluation, the standard for deciding whether to use xanthine or uric acid is basically the xanthine reduction standard. However, in the case where it is difficult to perform the analysis from the peak of xanthine due to the retention time of the components originally contained in the sample itself in the HPLC analysis, the uric acid production standard is used.
[0082] Example 2: Preparation of roasted barley In order to identify the xanthine oxidase inhibitory active components contained in barley tea, extracts of roasted six-rowed barley and two-rowed barley were prepared. The crushing L value was determined by crushing an appropriate amount of each barley for 5 to 15 seconds using a small ultra-high speed grinder (Wonder Blender, model number WB-1, manufactured by Osaka Chemical Co., Ltd.), visually confirming that there was no uncrushed material, and then measuring the surface color with a color difference meter (SE7720, manufactured by Nippon Denshoku Industries Co., Ltd.).
[0083] (Example 2-1) For the medium roasted six-row barley, Canadian Legacy was medium roasted according to the method described in Patent Publication No. 4456178. Specifically, the barley was subjected to steam spraying to adjust the moisture content to about 25% by weight, and the barley was placed in a rotary drum type medium roasting kiln and subjected to primary roasting at a roasting temperature of 255°C for 90 seconds. After that, water was sprayed in a shower at a rate of 0.17L / min to instantly (about 1 second) lower the temperature by 90°C, and the barley was rapidly cooled to a product temperature of 165°C. Next, secondary roasting was performed at a roasting temperature of 280°C for 90 seconds, and the roasted barley was transferred to the conveyor of the cooling device and slowly cooled by adjusting the speed of the cooling fan and conveyor so that the product temperature of the barley remained in the temperature range of 80 to 140°C for 47 seconds, to produce roasted barley. The crushing L value of the obtained roasted barley was 31.01.
[0084] (Example 2-2) The hot air roasted barley was made by putting 2 kg of unroasted grains of Canadian Legacy variety (six-row barley) or Australian Latrobe variety (two-row barley) into a small batch roaster (Tokyo Sanki Kogyo TG-5 batch roaster) and roasting them with hot air. The heat was adjusted appropriately, and when the product temperature reached the specified temperature, the barley was removed from the roaster and cooled to obtain each type of roasted barley. The crushing L values of the obtained roasted barley are shown in Tables 2 and 3.
[0085] (Example 2-3) The stationary roasted barley was prepared by heating 50 to 100 g of unroasted Canadian Legacy (six-row barley) grains using a hot plate (As One Ceramic Hot Plate CHP-170AF). Specifically, an aluminum plate (14 cm x 14 cm) was made with aluminum foil, and the above barley was placed on it, and then a heat-resistant glass plate was placed on the plate and the aluminum plate was heated (Method A), or the aluminum plate was placed directly on the plate and heated (Method B). After heating for 60 minutes at a set temperature of 250 degrees while stirring appropriately every 5 to 20 minutes, the barley was further prepared by stationary roasting for 120 minutes at a set temperature of 300 degrees while stirring appropriately every 5 to 20 minutes. The crushed L value of the obtained roasted barley is shown in Table 2.
[0086] Example 3: XOD inhibitory activity of roasted barley crude extract 2,000g of hot water at 95-100℃ was added to 100g of medium roasted six-row barley (Example 2-1), and the temperature was kept at 98±2℃ and extracted for 30 minutes while stirring every 5 minutes. The resulting extract was filtered through sieves (20 mesh and 80 mesh) and flannel, and then concentrated by vacuum and freeze-drying to obtain an extract. The extraction efficiency was 45.5% (Example 3-1 extract).
[0087] For activity evaluation, an assay solution was prepared so that the final concentration of the extract (Extract of Example 3-1) was 1 w / v %, and the solution was subjected to a test for evaluating xanthine oxidase inhibitory activity using the method shown in Example 1.
[0088] The test results showed that the inhibition rate was 57.0% ( XA ) and 54.9% (inhibition rate UA ) inhibited xanthine oxidase, indicating that roasted barley extract has inhibitory activity against xanthine oxidase.
[0089] Example 4: Roasting temperature and xanthine oxidase inhibition The effect of roasting barley on xanthine oxidase inhibitory activity was investigated.
[0090] (extraction) The medium roasted six-rowed barley (Example 2-1), hot air roasted (Example 2-2), and still roasted (Example 2-3) were roughly ground using a hand mill so that 95% remained on a 30 mesh. The hot air roasted two-rowed barley (Example 2-2) was also ground in the same manner. 20 times the volume of hot water at 95 to 100°C was added to each ground barley, and the temperature was kept at 97±2°C and extracted for 30 minutes while stirring every 5 minutes. The extract was filtered through a cloth and then filtered through a filter paper (Advantec Toyo Qualitative Filter Paper No. 1), and then concentrated by reduced pressure and freeze-drying to obtain an extract.
[0091] (Activity evaluation) The inhibitory activity was evaluated according to the method described in Example 1. The extraction efficiency of each barley and the inhibition rate (inhibition rate) at a final concentration of 1 w / v% for each extract were XA (%) are shown in the table below. [Table 2] [Table 3]
[0092] As shown in Tables 2 and 3, the inhibitory activity of unroasted barley was weak, and in the hot air roasted product, the inhibitory activity increased with increasing roasting temperature, indicating that the roasting process is important for this inhibitory activity. Specifically, a grinding L value of 80 or less, preferably 50 or less, and more preferably 40 or less, was good. On the other hand, at least in the case of six-row barley, the extraction efficiency decreased in the strongly roasted product, indicating that the grinding L value should be 15.5 or more, preferably 20 or more, taking into account the extraction efficiency, regardless of whether hot air, medium, or static standing was used.
[0093] Example 5: Extraction Solvents and Xanthine Oxidase Inhibition The effect of different extraction solvents from roasted barley on xanthine oxidase inhibitory activity was examined.
[0094] (extraction) Six-row barley medium roasted product (Example 2-1) (100 g) was crushed with a hand mill to a coarseness of 95% remaining on a 30-mesh sieve. 400 mL of n-hexane was added to the product, and the mixture was left to stand at room temperature for 17 hours for extraction, and the extract and residue were separated. The filtrate was concentrated by vacuum and freeze-drying to obtain a viscous liquid extract (Example 5-1 hexane extract extraction efficiency 0.874%). Next, 400 mL of methanol was added to the residue, and the mixture was left to stand at room temperature for 7 hours, and the extract and residue were separated. Methanol extraction was performed twice (Example 5-2 methanol extract extraction efficiency 2.97%). 2,000 g of hot water at 98±2°C was added to the residue after methanol separation, and the mixture was extracted for 30 minutes while maintaining the water temperature and stirring every 5 minutes. After the extraction procedure, the residue was removed using a hand sieve, and the resulting extract was filtered while still hot using flannel and filter paper (Advantec Toyo Qualitative Filter Paper No. 1). After cooling to approximately 30°C, the extract was concentrated by reducing pressure and freeze-drying to obtain a water extract of six-rowed barley (Example 5-3, hot water extract, extraction efficiency 56.5%).
[0095] (Activity evaluation) For each extract of Example 5, the inhibitory activity at a final concentration of 1 w / v % was evaluated according to the method described in Example 1. [Table 4]
[0096] As shown in Table 4, the hexane extract had weak inhibitory activity, the methanol extract had very strong activity, and the hot water extract had moderate activity. On the other hand, looking at the extraction efficiency of each extract against the raw material, the methanol extract showed strong inhibitory activity, but its proportion in the extract was small at 2.97% of the total. The hot water extract had moderate inhibitory activity, but accounted for 56.5% of the total extract, and it was estimated that this contributed greatly to the inhibitory activity of this extract, so separation of the hot water extract was carried out below.
[0097] Example 6: Molecular weight fractionation and xanthine oxidase inhibition The effect of different molecular weights of roasted barley extracts on xanthine oxidase inhibitory activity was examined.
[0098] (extraction) 100 g of six-rowed barley medium roasted product (Example 2-1) was ground with a hand mill to a coarseness such that 95% remained on a 30 mesh sieve. 400 mL of n-hexane was added to this and left to stand for 17 hours at 15 to 25°C. This was filtered with a paper filter (Advantec Toyo Qualitative Filter Paper No. 2) and then with a membrane filter (Advantec Toyo Mixed Cellulose 0.45 μm) to separate the residue (hexane residue) and the filtrate. After recovering the entire amount of the hexane residue, 400 mL of methanol was added and extracted for 6 hours (first time) at 15 to 25°C, and the extract and residue were separated with a paper filter (Advantec Toyo Qualitative Filter Paper No. 1). To this residue, 400 mL of methanol was added again and extracted for 15 hours at 15-25°C (second time), and similarly separated into extract and residue (methanol residue) by filter paper filtration (Advantec Toyo Qualitative Filter Paper No. 1). The entire amount of methanol residue was collected and air-dried in a draft at 15-25°C, after which 2,000 g of hot water at 98±2°C was added and extracted for 30 minutes while maintaining the water temperature and stirring every 5 minutes. After extraction, the entire amount was separated into solid and liquid using sieves of 20 mesh, 80 mesh, 200 mesh, and 500 mesh in that order, and the obtained filtrate was cooled at 5°C for 1 hour and then centrifuged (5°C 3000×g 15 minutes). The supernatant was filtered through a filter cloth and then finely filtered through Celite (Celite No. 545, Fujifilm Wako Pure Chemical Industries, Ltd.) to obtain an extract filtrate (Example 6 extract 1772.8 g, Bx 3.305%, extraction efficiency 58.6%).
[0099] (Molecular weight fractionation: filtration by ultrafiltration membrane) The extract of Example 6 was passed through an ultrafiltration filter unit Minimate system manufactured by Nippon Pall Co., Ltd. in the order of increasing nominal molecular weight and concentrated, and fractionated by molecular weight using an ultrafiltration membrane. The nominal cutoff molecular weight of the Minimate TFF capsule used in the Minimate system is 10K: 10,000, 5K: 5,000, 3K: 3,000, and 1K: 1,000. The fractionation procedure is shown in Figure 1. The fractionation operation by ultrafiltration was performed in each membrane until the solid concentration of the filtrate, i.e., the liquid discharged from the TFF capsule filtration side outlet (Vent or Filtrate), was less than Bx0.1%. Each fraction obtained was concentrated by vacuum and freeze-drying to obtain each solid matter (Example 6, Fractions 1 to 5).
[0100] Based on the method described in Example 1, the inhibitory activity at a final concentration of 1 w / v % was evaluated. [Table 5]
[0101] As can be seen from Table 5, the molecular weights of 10,000 or more (fraction 1 in Example 6) and 1,000 to 3,000 (fraction 4 in Example 6) showed less than 50% inhibitory activity, the molecular weights of 5,000 to 10,000 (fraction 2 in Example 6) and 3,000 to 5,000 (fraction 3 in Example 6) showed moderate inhibitory activity, while the low molecular weight fraction with a molecular weight of 1,000 or less (fraction 5 in Example 6) showed strong inhibitory activity.
[0102] Example 7: Various cereals and xanthine oxidase inhibition The effects of various cereal extracts on xanthine oxidase inhibitory activity were examined.
[0103] (extraction) Commercially available products were used for each grain. 20 times the weight of hot water at 95-100°C was added to each grain, and the temperature was maintained at 97±2°C while stirring every 5 minutes for 30 minutes. The extract was filtered through a flannel and a sieve (150 mesh) to separate the solid and liquid, cooled to 5°C, and centrifuged (1530×g, 5°C, 15 minutes) to precipitate insoluble matter. The supernatant was filtered through a flannel and a filter paper (Advantec Toyo Qualitative Filter Paper No. 1), concentrated by reduced pressure and freeze-drying, and the extract was obtained.
[0104] (Activity evaluation) The inhibitory activity was evaluated based on the method described in Example 1. The extraction efficiency (%) in the extraction procedure for each grain and the inhibition rate (inhibition rate) at a final extract concentration of 1 w / v% were calculated. XA (%) are shown in the table below. [Table 6]
Claims
1. An inhibitor of molybdenum-iron / sulfur-flavin hydroxylase, comprising an ingredient derived from roasted grain seeds as an active ingredient.
2. The method of claim 1, wherein the molybdenum-iron / sulfur-flavin hydroxylase is a xanthine oxidoreductase (XOR) selected from the group consisting of xanthine oxidase (XOD) and xanthine dehydrogenase (XDH).
3. The inhibitor according to claim 1 or 2, wherein the active ingredient is extracted by water or a hydrophilic solvent.
4. The inhibitor according to claim 1 or 2, wherein the molecular weight of the active ingredient is 5,000 or less, 3,000 or less, or 1,000 or less.
5. The inhibitor according to claim 1 or 2, wherein the molecular weight of the active ingredient is 100 or more.
6. The inhibitor according to claim 1 or 2, wherein the cereal grain is one or more selected from the group consisting of barley, rye, oats, soybean, pearl barley, corn and rice.
7. The inhibitor according to claim 1 or 2, wherein the barley is one or more types selected from the group consisting of six-row barley and two-row barley.
8. A uric acid production inhibitor comprising the inhibitor according to claim 1 or 2 as an active ingredient.
9. 3. An agent for suppressing the production of reactive oxygen species, comprising the inhibitor according to claim 1 or 2 as an active ingredient.
10. A food or drink comprising the inhibitor according to claim 1 or 2, the uric acid production inhibitor according to claim 8, or the reactive oxygen species production inhibitor according to claim 9.
11. A supplement comprising the inhibitor according to claim 1 or 2, the uric acid production inhibitor according to claim 8, or the reactive oxygen species production inhibitor according to claim 9.
12. A pharmaceutical composition for treating or preventing a disease in which inhibition of molybdenum-iron / sulfur-flavin hydroxylase is required, comprising as an active ingredient a component derived from roasted cereal seeds.
13. 13. The pharmaceutical composition of claim 12, wherein the disease is selected from the group consisting of hyperuricemia, inflammation, autoimmune disease, pulmonary disease, cardiovascular disease, sickle cell disease and cancer.
14. A method for producing a fraction containing a component that inhibits molybdenum-iron / sulfur-flavin hydroxylase, comprising the step of subjecting roasted grain seeds to extraction with one or more solvents selected from the group consisting of water and hydrophilic solvents.
15. 15. The method of claim 14, further comprising fractionating the extracted fraction according to molecular weight.
Citation Information
Patent Citations
Xanthine oxydase inhibotor
JP2000290188A
